-
Shimadzu incorporates AI in new chromatograph series
biospectrumasia
March 18, 2019
Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and design.
-
Project launched to tackle lab inefficiency, support AI adoption
europeanpharmaceuticalreview
March 13, 2019
A project backed by major pharma will advance the Lab of the Future with proof of concept software to digitise experiment methods…
-
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment
en-cphi.cn
March 12, 2019
Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, today announced a new project to develop AI algorithms for improving diagnosis and treatment of liver cancer.
-
IBM Watson Health Invests in Research Collaborations to Advance AI to Health
americanpharmaceuticalreview
February 15, 2019
IBM Watson Health announced plans to make a 10-year, $50 million investment in research collaborations with two separate academic centers - Brigham and Women's Hospital....
-
NHS should invest in digital, AI, and robotics training
pharmaphorum
February 13, 2019
The Topol Review of the training needs of the future NHS workforce has published its recommendations – including an increase in the number of clinicians trained to use digital, AI and robotics technologies.
-
A healthy 2019: Four paws for more relaxation and exercise
worldpharmanews
January 24, 2019
Pets spend their whole lives at their owners' sides, keeping them active and comforting them in times of illness or loneliness.
-
Novartis and University of Oxford partner on AI-based drug development
pharmaceutical-technology
January 22, 2019
Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics.....
-
GE Healthcare partners with Vanderbilt on AI-based immunotherapy guidance and diagnostics
fiercebiotech
January 15, 2019
GE Healthcare is teaming up with Vanderbilt University Medical Center to develop more precise cancer immunotherapy diagnostics that use artificial intelligence to predict both efficacy and potential side effects....
-
Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI
pharmaphorum
January 14, 2019
Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery.
-
Novartis puts AI on the job to help reps say the right things to the right doctors
fiercepharma
January 13, 2019
Amid far more meetings with digital companies at the J.P. Morgan Healthcare Conference this year, Novartis’ pharma CEO Paul Hudson said he expects 2019 to be the “beginning of the tech disruption” for pharma, in everything from marketing to supply chain.